Literature DB >> 12165054

Is hypertension a leading cause of heart failure in Chinese?

M Gary Nicholls1, A Mark Richards.   

Abstract

1. There is considerable uncertainty regarding the importance of various risk factors in the development of heart failure. Most data are from Caucasian populations, where hypertension and coronary artery disease appear dominant. 2. Because it cannot be presumed that risk factor profiles will be identical for all races, we reviewed the literature on the aetiology of heart failure in Chinese. 3. There are, apparently, no long-term prospective studies defining the risk factors for heart failure in Chinese. Studies from Hong Kong in the 1990s point to an overlap of risk factors (especially hypertension, ischaemic heart disease and diabetes) and a high prevalence of diastolic heart failure (66%). Antihypertensive drug treatment appears likely to protect against the development of heart failure but end-points from formal trials are too small to be certain. 4. Available data, short of being definitive, point to hypertension being the most important identifiable risk factor in Chinese with heart failure. This may change with diabetes mellitus becoming more prevalent in the Chinese population.

Entities:  

Mesh:

Year:  2002        PMID: 12165054     DOI: 10.1046/j.1440-1681.2002.03735.x

Source DB:  PubMed          Journal:  Clin Exp Pharmacol Physiol        ISSN: 0305-1870            Impact factor:   2.557


  2 in total

1.  Worse Prognosis in Heart Failure Patients with 30-Day Readmission.

Authors:  Ying-Chang Tung; Shing-Hsien Chou; Kuan-Liang Liu; I-Chang Hsieh; Lung-Sheng Wu; Chia-Pin Lin; Ming-Shien Wen; Pao-Hsien Chu
Journal:  Acta Cardiol Sin       Date:  2016-11       Impact factor: 2.672

2.  Under- treatment and under diagnosis of hypertension: a serious problem in the United Arab Emirates.

Authors:  Abdishakur M Abdulle; Nico Jd Nagelkerke; Samra Abouchacra; Javed Y Pathan; Abdu Adem; Enyioma N Obineche
Journal:  BMC Cardiovasc Disord       Date:  2006-06-06       Impact factor: 2.298

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.